Foster City, Calif., 5 Oct 2024: Pharmaceutical giant Gilead Sciences approved new license agreements for lenacapavir, an antiretroviral medication which provides near-total protection from HIV infection. 

 

The drug, packaged ......
View Details

Related News

• Critical medicines for cancer, diabetes set to get expensive as govt clears price hike, say sources (27-03-2025)

---

• DGFT proposes mandatory GST E-Invoices for pharma export benefits (27-03-2025)

---

• US FDA approves first treatment for rare genetic disorder Prader-Willi syndrome (27-03-2025)

---

• FDA approves GSK’s 'Blujepa' for uncomplicated UTIs (27-03-2025)

---

• Bengal drug control publishes helpline to report fake medicines (27-03-2025)

---

• Misleading ads: SC asks states UTs to set up grievance redressal mechanism (26-03-2025)

---

• WHO partners with regulators, experts to strengthen safety and access of medical devices (26-03-2025)

---

• PCI warns of tough action against inspectors who don't follow its guidelines during inspection (26-03-2025)

---

• Seizure of fake Human Albumin Vials rings alarm bells (26-03-2025)

---

• Pharmacy owner, three others held for illegal sale of intoxication drug (26-03-2025)

---